Learn about prostate cancer signs, diagnosis, causes, risk factors, and treatment options. Five-year survival rate: 98%. Annual diagnoses: 191,000. Most diagnoses occur after age 55.
Finding a clear answer on when – or even if – men should get prostate cancer screening can be difficult.
Learn about prostate cancer diagnosis, the methods used to determine it, risk assessment information and the Gleason Grading System.
Discover the latest prostate cancer treatment options, as well as information on sexuality and fertility after treatment.
Warning signs of prostate cancer often only show up once the cancer has spread. Here, urologic oncologist Lisly Chéry, M.D., shares prostate cancer symptoms to look out for.
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone therapy improved progression-free survival (PFS) in patients with oligometastatic prostate cancer. Findings from the multicenter EXTEND trial were presented today at the 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting.
New research shows that men who receive care at multidisciplinary prostate clinics are more likely to receive treatments that adhere to the national standard of care, participate in discussions with their doctors and have a say in their treatment options.
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
Newly diagnosed prostate cancer patients have multiple standard-of-care treatment options available, but many are not fully informed of their choices. A study led by researchers at The University of Texas MD Anderson Cancer Center found men who seek treatment at a multidisciplinary (MultiD) prostate cancer clinic are more likely to be advised about treatment choices and to receive care that complies with evidence-based treatment guidelines. African American men who visited the MultiD clinic also were more likely to receive definitive, or curative, therapy, compared with national trends.
Stereotactic body radiation therapy (SBRT) is a type of radiation therapy that uses a more focused beam of radiation that allows us to target the tumor more precisely for patients undergoing prostate cancer treatment. Karen Hoffman, M.D., explains how this radiation therapy offers prostate cancer patients an excellent treatment option in less time with similar long-term side effects.